Huw Evans > Gowling WLG > London, England > Lawyer Profile

Helmed by Kate Swaine, Gowling WLG provides a full-service offering to its global clients, with core streams of work being comprised of patent litigation spanning technology, telecoms, and life sciences, and SEP/FRAND strategy and litigation, as well as AI-related mandates. Paul Inman is recommended for his expertise in handling blockbuster disputes for notable names in the pharmaceutical space, and Alexandra Brodie is a strong choice for a plethora of technology products, including AI, blockchain, quantum computing, and cyber security. Patrick Duxbury is distinguished on the transactional side, and Huw Evans is an established presence in the healthcare and technology sectors, with Luke Kempton leveraging his biochemistry experience to operate within the biotech and pharmaceutical arenas. Matt Hervey‘s capabilities encompass AI, SEP/FRAND, life sciences, and automotive issues.

The likes of GlaxoSmithKline, Lundbeck and Neurim Pharmaceuticals turn to the team at Gowling WLG for assistance with issues spanning patent disputes, IP portfolio management, joint ventures, M&A, and commercial agreements. The unit is also active across digital health and well-placed to assist funders and operators of care homes and senior living facilities with a range of issues. Practice head Robert Breedon, who divides his time between Birmingham and London, frequently leads on large healthcare projects. Paul Inman has a proven track record in multi-jurisdictional patent litigation. Patrick Duxbury‘s varied caseload includes global collaborations and co-commercialisation deals. Huw Evans‘ busy portfolio of work includes patent entitlement cases in the French and Spanish Courts. Luke Kempton’s scientific expertise is particularly prized by Japanese companies seeking assistance with drug acquisition, collaboration and licensing deals. Mathilda Davidson specialises in transactional IP matters, while patent expert Christopher Freeth has notable experience with Arrow declarations.